CAPTRUST Financial Advisors
AVNS

CAPTRUST Financial Advisors’s Avanos Medical AVNS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,984
Closed -$154K – 3289
2026
Q1 		$154K Buy
10,984
+18
+0.2% +$243 ﹤0.01% 2739
2025
Q4 		$123K Sell
10,966
-3,270
-23% -$37.4K ﹤0.01% 2589
2025
Q3 		$165K Buy
+14,236
New +$167K ﹤0.01% 2458
2022
Q3 		– Sell
-2,507
Closed -$69K – 2228
2022
Q2 		$69K Sell
2,507
-197
-7% -$5.66K ﹤0.01% 2495
2022
Q1 		$91K Buy
2,704
+521
+24% +$16.8K ﹤0.01% 2344
2021
Q4 		$76K Buy
2,183
+295
+16% +$9.54K ﹤0.01% 2355
2021
Q3 		$59K Sell
1,888
-176
-9% -$5.97K ﹤0.01% 2464
2021
Q2 		$75K Sell
2,064
-268
-11% -$11.1K ﹤0.01% 2229
2021
Q1 		$102K Sell
2,332
-3,350
-59% -$157K ﹤0.01% 1932
2020
Q4 		$261K Buy
5,682
+30
+0.5% +$1.25K ﹤0.01% 1087
2020
Q3 		$187K Sell
5,652
-382
-6% -$12.2K ﹤0.01% 1061
2020
Q2 		$181K Buy
+6,034
New +$175K ﹤0.01% 1074
2019
Q4 		– Sell
-5,131
Closed -$192K – 1063
2019
Q3 		$192K Sell
5,131
-51
-1% -$1.95K 0.01% 583
2019
Q2 		$226K Buy
5,182
+3,904
+305% +$167K 0.01% 536
2019
Q1 		$55K Buy
1,278
+52
+4% +$2.33K ﹤0.01% 879
2018
Q4 		$55K Sell
1,226
-279
-19% -$14.6K ﹤0.01% 755
2018
Q3 		$103K Buy
1,505
+1,021
+211% +$65.7K ﹤0.01% 585
2018
Q2 		$28K Sell
484
-19
-4% -$1K ﹤0.01% 848
2018
Q1 		$23K Buy
503
+176
+54% +$8.36K ﹤0.01% 779
2017
Q4 		$15K Buy
+327
New +$15K ﹤0.01% 873

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

CAPTRUST Financial Advisors's AVNS Position: Q2 2026 in Review

CAPTRUST Financial Advisors sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 10,984 shares — an estimated $154K sold.

CAPTRUST Financial Advisors first reported a position in AVNS in Q4 2017 and held it in 20 quarters. The position peaked at $261K in Q4 2020. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • CAPTRUST Financial Advisors reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,984 Avanos Medical shares in Q2 2026, an estimated $154K.
  • CAPTRUST Financial Advisors first reported a position in Avanos Medical in Q4 2017 and held it in 20 quarters.
  • CAPTRUST Financial Advisors's Avanos Medical position peaked at $261K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.